INTRODUCTION
Usher syndrome (USH) is an autosomal recessive disease, characterized by sensorineural hearing impairment associated with retinitis pigmentosa, which affects one child in 25 000. It is regarded as the most frequent cause of hereditary deaf-blindness in humans. Among the three distinct clinical subtypes, USH type I (USH1) is the most severe form, characterized by profound congenital sensorineural hearing loss, constant vestibular dysfunction and prepubertal onset retinitis pigmentosa. USH1 is reported to be responsible for half of the Usher cases. Three USH1 loci, USH1A, 1B and 1C, have been mapped to the chromosome bands 14q32 (1), 11q13.5 (2,3) and 11p15 (3), respectively. However, in several families affected by USH1, the disease has not been found to segregate with any of these loci, thus indicating the existence of at least one additional USH1 locus (4) . Recently, a fourth locus, USH1D has been assigned to chromosome 10q (5).
At present, only the USH1B gene, which has been estimated to account for 75% of USH1 cases according to studies performed in Western countries, has been cloned (6, 7) . This gene codes for myosin VIIA, a putative actin-based motor protein. In humans, the gene is expressed from embryonic life onwards, in the cochlear and vestibular hair cells as well as in the retinal photoreceptor and pigment epithelial cells (7, 8) .
Here, we report on the mapping of a new locus responsible for USH1, USH1E, to the 21q21 chromosomal region, by segregation analysis of a consanguineous family originating from Morocco (4).
RESULTS
The diagnosis of Usher syndrome in this family was established by an ophthalmological examination motivated by the appearance of visual problems in the first child. The parents, originating from Morocco, were second cousins. They had six children, three sons and three daughters. The first and the fourth child were recognized as deaf before 2 years of age because of the absence of spontaneous language. The four other children had normal hearing. At the time of the ophthalmological examination, the two affected children were 12 and 7 years old. Retinitis pigmentosa was diagnosed in both of them, based on concentric loss of visual field, granular accumulation of pigment at the ocular fundus and non-recordable electroretinogram. The two affected children were subjected to a pure tone audiometry with aerial and bone conduction analysis, which revealed a hearing loss up to 120 dB HL at all frequencies. In addition, complete bilateral vestibular areflexia upon caloric stimulation and by rotational tests was observed. This syndrome could thus be unambiguously classified as USH1.
At first, this family was tested for cosegregation of the disease with each of the four previously mapped USH1 loci (USH1A, 1B, 1C and 1D), using polymorphic markers specific for each locus (see Materials and Methods). No region of homozygosity by descent was observed, nor cosegregation of the disease with any of these markers (data not shown), thus excluding the involve-*To whom correspondence should be addressed ment of the four USH1 loci in this family. Therefore, every individual from this family was genotyped with microsatellite markers belonging to the Généthon panel of polymorphic markers, which are distributed every 15-20 cM over the entire human genome (9) . After having explored 118 markers, the segregation analysis of marker D21S265 revealed that the two affected children were homozygous and the four unaffected children heterozygous for this marker (Fig. 1) . Flanking markers were then tested in order to delimit the region of homozygosity in the affected children. The two affected children were found to be homozygous for the markers D21S1914, D21S1257, D21S1918, D21S1884, D21S1922 on the proximal side of D21S265 and for the markers D21S1896, D21S1258, D21S1916 on the distal side (Figs 1 and 2 ). The homozygosity region thus extends at least 12 cM. The closest non homozygous markers, D21S1905 on the proximal side and D21S1913 on the distal side, are 15 cM apart (9) . All unaffected children were heterozygous for these markers. LOD score analysis across this chromosomal region was performed using the MAPMAKER/HOMOZ program (10) . Multipoint linkage analysis with the above mentioned markers gave a maximum LOD score of 4.21 at θ = 0 cM for D21S1914, assuming an allelic frequency of the markers of 0.1. A 100-fold change in the frequency of the linked alleles (from 0.002 to 0.2) resulted in only a minor variation of the maximum multipoint LOD score. These results therefore define the fifth locus for USH1, USH1E.
The involvement of the USH1E locus was subsequently tested in two other families affected by USH1, in which the segregation of the disease was not consistent with the involvement of the USH1A, 1B, 1C and 1D loci (Fig. 3) . In none of them was the segregation of the disease consistent with the involvement of USH1E either (Fig. 3) , indicating that there exists at least one more USH1 locus.
DISCUSSION
Homozygosity mapping is a particularly appropriate approach for mapping rare and genetically heterogeneous autosomal recessive diseases to human chromosomes (10, 11) . Using this approach, we mapped a new locus for the USH1 syndrome, USH1E, to the long arm of chromosome 21, between the loci D21S1905 and D21S1913, which are 15 cM apart. According to the assignment of the D21S120 marker and IFNAR gene, which frame the USH1E chromosomal interval, to 21q11.2 and 21q22.1, respectively (12, 13) , USH1E is expected to lie within 21q21. It is noteworthy that this localization is different from the 1q41 and 3q21-25 chromosomal localizations previously reported for USH2 (14, 15) and USH3 (16), respectively.
We previously mapped a recessive form of human isolated deafness, DFNB2 (17) , to the same region as USH1B, which suggests that the same gene (6,7) could be responsible for the two diseases. We thus examined whether some of the identified loci for isolated forms of hearing loss may be allelic variants of the USH1E gene. The loci for both the dominant (DFNA) and the recessive (DFNB) forms of isolated deafness were taken into consideration, since the colocalizations of DFNB1 and DFNA3 (18, 19) , DFNB2 and DFNA11 (17, 20) and DFNB5 and DFNA9 (21, 22) , suggest that a single gene could be involved in both dominant and recessive forms of deafness. A total of 10 DFNB loci and 11 DFNA loci have now been characterized (see reference 23, for a review), none of which maps to 21q21.
About a hundred mouse mutants having a hearing loss, either associated with other phenotypic anomalies or not, have been described (24) ; such mutants have already greatly facilitated the cloning of the human orthologous genes (6, (25) (26) (27) (28) (29) . A single mouse mutant presenting an Usher-like phenotype, rd5, has been reported so far, but it maps to a region homologous to 11p15 and has consequently been proposed to be the mouse equivalent of USH1C (30) . However, as the shaker-1 phenotype in mice, characterized by isolated inner ear defect without any retinal defect, and the USH1B syndrome in humans have been shown to result from mutations in orthologous genes (6,25), we also considered the possible existence of a deaf mouse mutant in the murine chromosomal region homologous to the human 21q21; this region is expected to be located on mouse chromosome 16 (31, 32) . No deaf mouse mutant harbouring only an inner ear defect has yet been assigned to this chromosome. Extending the search to the deaf mouse mutants exhibiting additional phenotypic features, we found a single mutant assigned to chromosome 16, Bst (belly spot and tail), which would map to the junction of one region homologous to human chromosome 3q and another region homologous to the human 21q21. Because this mutant presents various additional phenotypic features affecting several organs and tissues (reduced body size, anomaly of the spine and eyes, polydactyly), it seems unlikely that it could result from a defect in the murine orthologous USH1E gene.
Until now, only three genes have been mapped to the 21q21 chromosomal region: the gene encoding enterokinase, a duodenal serine protease, the STCH gene encoding a protein belonging to the stress 70 protein chaperone family and, finally, the gene encoding the E4TF1 transcription factor. The first of these genes is unlikely to be expressed in the inner ear. The other two can be considered as candidates for USH1E, although so far there is no indication that they might be involved in a sensorineural defect.
In the search for USH candidate genes, considerable attention should be payed to cytoskeletal components. Indeed histopathological studies have revealed abnormal microtubular organization of the axoneme of the photoreceptor cells (33, 34) , nasal ciliar cells (35, 36) and sperm cells (34) in some Usher patients. Besides, the demonstration of the myosin VIIA gene as being responsible for USH1B (6) has focused interest on proteins interacting with the actin network. Together, these data suggest that at least some of the USH proteins could belong to one large protein complex, interacting with both the microtubule and microfilament networks.
MATERIALS AND METHODS

Genotyping
Three families were analysed, one consanguineous from Morocco, named USHMO1 and referred to as family 1 in reference (4), one non-consanguineous from Lebanon, USHLB3 (comprising two affected and six unaffected siblings), and one small consanguineous (parents are first cousins) from Tunisia, USHTU5. The genomic DNAs were prepared from 5-10 ml of blood by standard phenol-chloroform extraction. Microsatellite markers were amplified by the polymerase chain reaction (PCR) and analysed on polyacrylamide gels as previously described. The Généthon markers used to exclude the four previously identified USH1 loci were: D14S267, D14S250, D14S78, D14S51, D14S260 for USH1A, D11S1321, D11S527, D11S4186, D11S937 for USH1B, D11S419, D11S902, D11S921, D11S899 for USH1C and D10S584, D10S535, D10S580, D10S569, D10S532 for USH1D. The markers used to characterize locus USH1E were: D21S1905, D21S1922, D21S1884, D21S1918, D21S1257, D21S1914, D21S265, D21S1896, D21S1258, D21S1916, D21S1913; the sequences of the corresponding primers have been reported (9) .
Linkage analysis
LOD scores were calculated using the MAPMAKER/HOMOZ program (10) (version 0.9), a new algorithm for rapid multipoint analysis. The disease was assumed to be inherited in a recessive mode and fully penetrant. The gene frequency was set at 10 -5 and the variation of this frequency between 10 -3 and 10 -5 resulted in negligible variation of the multipoint LOD scores. Meiotic recombination frequencies were assumed to be equal for males and females. The allele frequencies of the polymorphic markers were assumed to be equal.
